Narus Financial Partners LLC Buys New Shares in Docusign Inc. $DOCU

Key Points

• Narus Financial Partners LLC acquired a new stake in Docusign Inc., purchasing 3,836 shares worth approximately $299,000 during the second quarter.
• A significant proportion of Docusign's stock, about 77.64%, is owned by hedge funds and institutional investors, highlighting strong interest in the company.
• Docusign exceeded analysts' earnings expectations by reporting $0.92 EPS for the quarter and a revenue of $800.64 million, reflecting an 8.8% year-over-year revenue increase.

Narus Financial Partners LLC purchased a new position in shares of Docusign Inc. (NASDAQ:DOCU - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 3,836 shares of the company's stock, valued at approximately $299,000.

A number of other institutional investors have also modified their holdings of the stock. Avanza Fonder AB purchased a new stake in shares of Docusign in the second quarter valued at approximately $969,000. Mitchell & Pahl Private Wealth LLC boosted its position in Docusign by 2.7% during the second quarter. Mitchell & Pahl Private Wealth LLC now owns 21,273 shares of the company's stock worth $1,657,000 after purchasing an additional 556 shares in the last quarter. Farther Finance Advisors LLC lifted its position in shares of Docusign by 67.6% in the second quarter. Farther Finance Advisors LLC now owns 8,089 shares of the company's stock valued at $630,000 after acquiring an additional 3,262 shares in the last quarter. Assenagon Asset Management S.A. lifted its position in shares of Docusign by 114.1% in the second quarter. Assenagon Asset Management S.A. now owns 512,970 shares of the company's stock valued at $39,955,000 after acquiring an additional 273,357 shares in the last quarter. Finally, Perpetual Ltd lifted its position in shares of Docusign by 30.4% in the second quarter. Perpetual Ltd now owns 10,635 shares of the company's stock valued at $828,000 after acquiring an additional 2,481 shares in the last quarter. Institutional investors and hedge funds own 77.64% of the company's stock.

Insider Activity

In other news, Director Anna Marrs sold 728 shares of the business's stock in a transaction dated Monday, September 15th. The stock was sold at an average price of $80.30, for a total value of $58,458.40. Following the transaction, the director directly owned 10,799 shares of the company's stock, valued at $867,159.70. The trade was a 6.32% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Peter Solvik sold 15,000 shares of the business's stock in a transaction dated Monday, September 15th. The shares were sold at an average price of $81.48, for a total value of $1,222,200.00. Following the completion of the transaction, the director directly owned 135,253 shares in the company, valued at $11,020,414.44. This represents a 9.98% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 82,533 shares of company stock worth $6,598,028. 1.66% of the stock is owned by insiders.

Docusign Stock Up 0.3%

Shares of Docusign stock traded up $0.27 during trading on Monday, reaching $84.86. 1,935,665 shares of the company were exchanged, compared to its average volume of 3,496,048. Docusign Inc. has a twelve month low of $58.00 and a twelve month high of $107.86. The firm has a market capitalization of $17.07 billion, a price-to-earnings ratio of 63.80, a P/E/G ratio of 4.43 and a beta of 1.02. The business has a 50-day moving average price of $76.56 and a 200-day moving average price of $79.31.

Docusign (NASDAQ:DOCU - Get Free Report) last posted its earnings results on Thursday, September 4th. The company reported $0.92 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.84 by $0.08. The firm had revenue of $800.64 million during the quarter, compared to analysts' expectations of $780.35 million. Docusign had a return on equity of 14.01% and a net margin of 9.08%.The company's revenue was up 8.8% on a year-over-year basis. During the same period in the previous year, the firm earned $0.97 earnings per share. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. On average, equities research analysts forecast that Docusign Inc. will post 1.17 EPS for the current fiscal year.

Docusign declared that its board has initiated a stock repurchase plan on Thursday, June 5th that allows the company to repurchase $1.00 billion in shares. This repurchase authorization allows the company to repurchase up to 6.6% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company's leadership believes its stock is undervalued.

Wall Street Analyst Weigh In

Several research firms recently commented on DOCU. JPMorgan Chase & Co. upped their target price on Docusign from $77.00 to $80.00 and gave the company a "neutral" rating in a research note on Friday, September 5th. Argus reissued a "hold" rating on shares of Docusign in a report on Monday, September 8th. Royal Bank Of Canada increased their target price on Docusign from $90.00 to $95.00 and gave the stock a "sector perform" rating in a report on Friday, September 5th. Wells Fargo & Company increased their price target on Docusign from $80.00 to $85.00 and gave the stock an "equal weight" rating in a research report on Friday, September 5th. Finally, Robert W. Baird raised their target price on Docusign from $85.00 to $90.00 and gave the company a "neutral" rating in a research report on Friday, September 5th. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and fourteen have issued a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of "Hold" and an average price target of $94.14.

Docusign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.